Connect With Us
Subscribe Now
Log In
Home
News
Education
Health
Tech
STEM
Advanced Manufacturing & Logistics
Life Sciences
Ag INnovation
INPower
Videos
Big Wigs
Submit Big Wigs
Events
Innovate Southwest Indiana â Evansville
Innovate West Central Indiana – Terre Haute
Innovate East Central – Muncie
Innovate Northeast Indiana – Fort Wayne
Newsletters
Podcasts
On-Air
TV & Radio Listings
Content Studio
Sponsored Content
Contact
About IIB
Meet the Team
Contact Us
Advertise
Gift Cards
Flagship Stations
Gerry’s Message
Speaking Engagement Request
Search
GO
Connect With Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Biogen Inc
Recent news which mentions Biogen Inc
< Previous
1
2
3
4
Next >
ALS and the crushing cost of care: How 4 Americans face the 'bankruptcy disease'
May 14, 2026
Tags
Make It / Make It and Save
Make It
Biogen Inc
From
CNBC.com News
Biogen advances Alzheimer's drug to late-stage trial despite disappointing data
May 14, 2026
Tags
Biotech and Pharmaceuticals
Health care industry
Biogen Inc
From
CNBC.com News
Trump's pharmaceutical tariffs could affect some drugmakers more than others
July 29, 2025
Tags
Business
Biogen Inc
Roche Holding AG
From
CNBC.com News
FDA taps biotech industry veteran as RFK Jr.'s top drug regulator
July 21, 2025
Tags
Business News
Health care industry
Breaking News: Business
From
CNBC.com News
Trump's tariffs are a new challenge for Big Pharma. Here are the best positioned stocks
April 01, 2025
Tags
Health care industry
Breaking News: Markets
Breaking News: Investing
From
CNBC.com News
Biogen beats estimates on cost cuts and new drugs like Leqembi, but profit outlook falls short
February 12, 2025
Tags
Breaking News: Earnings
Health care industry
Business News
From
CNBC.com News
5 things to know before the stock market opens Monday
February 10, 2025
Tags
Politics
Restaurant Brands International Inc
Investment strategy
From
CNBC.com News
Bristol Myers Squibb says Alzheimer's is the biggest market for new schizophrenia drug
January 15, 2025
Tags
Health & Science
Biotechnology
US: News
From
CNBC.com News
Biogen tops estimates, raises profit guidance as Alzheimer's drug Leqembi gains traction
October 30, 2024
Tags
Business News
Health care industry
Breaking News: Earnings
From
CNBC.com News
Wednesday's big stock stories: What’s likely to move the market in the next trading session
October 29, 2024
Tags
KB Home
stocks
PRO: Playbooks
From
CNBC.com News
5 things to know before the stock market opens Monday
October 28, 2024
Tags
Berkshire Hathaway Inc
Business
Biogen Inc
From
CNBC.com News
Thursday's big stock stories: What's likely to move the market in the next trading session
September 25, 2024
Tags
Trane Technologies PLC
Investing
Lockheed Martin Corp
From
CNBC.com News
5 things to know before the stock market opens Monday
September 09, 2024
Tags
5 Things to Know
Business News
Economy
From
CNBC.com News
Alzheimer's drug Leqembi promises to give patients more time, but they face a long road to treatment
September 08, 2024
Tags
Business News
Health care industry
Science
From
CNBC.com News
Biogen beats expectations, hikes outlook as Alzheimer's drug Leqembi and other new products gain traction
August 01, 2024
Tags
Pharmaceuticals
Breaking news
Business
From
CNBC.com News
Patients on Alzheimer's drug Leqembi see benefits over three years, Eisai study says
July 30, 2024
Tags
Science
Health care industry
Business News
From
CNBC.com News
Older GLP-1 drug from Novo Nordisk may slow Alzheimer's disease progression by protecting the brain, study says
July 30, 2024
Tags
Business
Biogen Inc
Companies
From
CNBC.com News
European drug regulator rejects Alzheimer's treatment Leqembi from Biogen, Eisai
July 26, 2024
Tags
Health & Science
Biotech and Pharmaceuticals
US: News
From
CNBC.com News
Jim Cramer says Eli Lilly isn't a 'one trick pony' after FDA advisers endorse its Alzheimer's drug
June 11, 2024
Tags
U/S/ Markets
Biogen Inc
Business
From
CNBC.com News
Cramer's Lightning Round: Bank of America is a buy
May 10, 2024
Tags
U/S/ Markets
Fidelis Insurance Holdings Ltd
Biogen Inc
From
CNBC.com News
Biogen tops quarterly profit estimates as cost cuts take hold, Leqembi launch picks up
April 24, 2024
Tags
Breaking news
Eisai Co Ltd
Pharmaceuticals
From
CNBC.com News
5 things to know before the stock market opens Monday
April 22, 2024
Tags
Hasbro Inc
Business News
General Motors Co
From
CNBC.com News
Eli Lilly says FDA delays approval of Alzheimer's drug in surprise move
March 08, 2024
Tags
Eisai Co Ltd
Pharmaceuticals
Companies
From
CNBC.com News
Healthy Returns: The launch of breakthrough Alzheimer’s drug Leqembi is off to a slow start
February 20, 2024
Tags
Health & Science
Biotech and Pharmaceuticals
Healthy Returns
From
CNBC.com News
Biogen revenue and profit shrink on Aduhelm costs, slumping sales of multiple sclerosis therapies
February 13, 2024
Tags
Biogen Inc
Business
Companies
From
CNBC.com News
5 things to know before the stock market opens Monday
February 12, 2024
Tags
Business News
5 Things to Know
Economy
From
CNBC.com News
Biogen drops controversial Alzheimer's drug Aduhelm to focus on Leqembi, experimental treatments
January 31, 2024
Tags
Health & Science
Biotech and Pharmaceuticals
US: News
From
CNBC.com News
Weight loss drugs, Alzheimer's treatments and gene editing: Enormous firsts defined 2023 in pharma
December 20, 2023
Tags
Companies
Biogen Inc
Business
From
CNBC.com News
5 things to know before the stock market opens Monday
November 06, 2023
Tags
Biogen Inc
Business
Rivian Automotive Inc
From
CNBC.com News
More convenient form of breakthrough Alzheimer's drug Leqembi shows promising results in study
October 25, 2023
Tags
Health care industry
Business News
Science
From
CNBC.com News
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.